May 24 (Reuters) – A U.S. advisory panel on Tuesday
recommended approval of a new diabetes drug made by Novo Nordisk
A/S that combines two of its existing treatments in a
fixed-dose combination…
The post RPT-UPDATE 2-U.S. FDA panel recommends approval of Novo Nordisk diabetes drug appeared first on NASDAQ.